Health & well-being
Oxygen Treatment may improve language, eye-contact, social interaction, irritability, or hyperactivity.
Double-blind, randomized, placebo-controlled studies are the gold standard of proof in the pharmaceutical drug testing model. An increasing number of such studies are demonstrating beyond a reasonable doubt that Oxygen Treatment, in certain circumstances, may alleviate many of the symptoms associated with MS by addressing the scleroses as they occur. As a consequence, there is mounting evidence that regular treatment with Oxygen Treatment may also significantly retard the progress of the condition
Fischer BH, Marks M, Reich T. (1983) Hyperbaric-oxygen treatment of multiple sclerosis: A randomized,placebo-controlled, double-blind study. N Engl J Med; 308:181-6.No 4
G. Oriani, S. Bartieri, G. Cislaghi, G. Albonico, G. Scarlato, C. Mariani, and C. Pirovano Journal of Hyperbaric Medicine, Vol. 5, No. 4, 1990, Long-term Hyperbaric Oxygen in Multiple Sclerosis: A Placebo-controlled, Double-blind Trial With Evoked Potentials Studies
D J D Perrins , P B James IJNN 2005 ; 2 (1): 45 – 48 © RPA Publications. Long-term hyperbaric oxygenation retards progression in multiple sclerosis patients
I now have 20 years of follow-up on two of my first MS patients. One continues to have minimal symptoms. Another, whose condition was more advanced, had been told that she would be bedridden in 6 months if she did not take methotrexate, a treatment that is no longer recommended. She opted for HBOT and other alternative treatments, completed her Ph.D., had two children, and continues to practice as a speech therapist, although she now uses a wheelchair. Her initial prognosis for remaining time until incapacitation was off by a factor of about 40.
Journal of American Physicians and Surgeons Volume 10 Number 4 Winter 2005 p116 William S. Maxfield, M.D., F.A.C.N.M.
“Obviously any treatment capable of eradicating or providing long-term prevention of multiple sclerosis automatically will serve the additional purpose of allowing a current acute episode to subside as rapidly as nature will permit the lesion to repair itself.”
George A. Schumcher
Barnes MP, Bates D, Cartlidge NEF et al (1985) Hyperbaric oxygen and multiple sclerosis: short term results of a placebo-controlled, double-blind trial. Lancet ii:297-300.
Barnes MP, Bates D, Cartlidge NEF et al (1987) Hyperbaric oxygen and multiple sclerosis: final results of a placebo-controlled, double-blind study. J Neurol Neurosurg Psychiatry 50: 1402-1406.
Wiles CM, Clarke CRA, Irwin HP et al (1986) Hyperbaric oxygen in multiple sclerosis: a double blind study.Br Med J 292:367-371
Oriani G, Barbieri S, Pirovano C, Mariani C (1987) Hyperbaric oxygen in chronic progressive multiple sclerosis : a placebo-controlled, double-blind, randomised study with evoked potentials evaluation. In: Oriani G (ed) Proceedings of the thirteenth annual meeting of the European Undersea Biomedical Society.Palermo: European Undersea Biomedical Society: 196-203.
Pallotta R, Longobardi G, Fabbrocini G (1986) Experience in protracted follow-up on a group of multiple sclerosis patients periodically treated with hyperbaric oxygen therapy. In Baixe J-H (ed). Symposium sur le traitment de la sclerose multiple par l'oxygene hyperbare. Paris.
Perrins DJD, James PB.(1994) The treatment of Multiple Sclerosis with prolonged courses of hyperbaric oxygen. Proceedings of the 1st European Consensus Conference on Hyperbaric Medicine. Lille : 245-263